WEX Inc. (WEX) Stock Price & Analysis
WEX Inc. (WEX) closed at USD 198.14 on Thursday, October 22, 2026, up 5.65% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 198.14; the Oct 22, 2026 session ranged USD 186.95–198.32 on volume of 475,296 shares. Market capitalization is —, with a 52-week range of USD 125.29–203.99 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/WEX.md
Key facts (WEX)
- 1 of 80 tracked superinvestors hold WEX (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Total return with dividends: 1Y +23.8% vs S&P 500 +14.9%; 5Y +1.8% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 5.66, revenue estimate $750M.
Superinvestors (SEC 13F-HR, Q2 2026) (WEX)
1 of 80 tracked investors hold WEX. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| John Rogers | Ariel Investments | 0.47% | $46.8M | Reduced -1.9% |
Analysts (WEX)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-11 | Piper Sandler | Initiated | Neutral | $209 |
| 2026-07-24 | Mizuho | Target raised | Outperform | $170 → $200 |
| 2026-07-24 | Keefe, Bruyette & Woods | Target raised | Outperform | $200 → $210 |
| 2026-07-21 | Morgan Stanley | Target raised | Equal-Weight | $161 → $172 |
| 2026-06-29 | Cantor Fitzgerald | Target lowered | Neutral | $173 → $152 |
Total return (dividends reinvested) (WEX)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +23.8% | +1.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +23.9% | +0.3% |
| Volatility (annualized) | 41.3% | 37.6% |
| Max drawdown | -31.4% (Apr 2026→Jun 2026) | -48.6% (Apr 2024→Apr 2025) |
WEX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $5.66 | $5.45 | +3.9% | $749.7M | 14 |
| Next quarter (ends Dec 2026) | $4.99 | $4.70 | +6.2% | $718.3M | 13 |
| Current fiscal year (ends Dec 2026) | $20.14 | $19.34 | +4.1% | $2.90B | 15 |
| Next fiscal year (ends Dec 2027) | $21.29 | $20.29 | +4.9% | $2.94B | 15 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 198.14 |
|---|---|
| Change | ▲ 5.65% (up) |
| Previous Close | USD 198.14 |
| Open | USD 198.14 |
| Day Range | USD 186.95 – 198.32 |
| 52-Week Range | USD 125.29 – 203.99 |
| Volume | 475,296 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (WEX)
Nexqual's technical model rates WEX "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 69.22 (neutral) |
| vs SMA50 | Above (USD 186.72) |
| MACD | 1.22 (positive) |
Earnings (WEX)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 5.66 |
| Revenue Estimate | $749.66M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 5.35 vs est 5.07 ▲ beat |
| 2026-03-31 | USD 4.15 vs est 4.1 ▲ beat |
| 2025-12-31 | USD 4.11 vs est 3.93 ▲ beat |
| 2025-09-30 | USD 4.59 vs est 4.45 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (WEX)
| Total Revenue | $2.79B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +14.20% |
| Gross Margin | +73.23% |
| Operating Margin | +26.94% |
| Profit Margin | +12.56% |
| ROE | +30.19% |
| Debt / Equity | 3.98 |
| Current Ratio | 1.05 |
| Total Cash | $6.10B |
| Total Debt | $5.36B |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $313.70M (11.8% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (WEX)
Nexqual rates WEX Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Mixed — Revenue +1.2% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 27% (last 12 months) |
| Balance Sheet | Critical — $6.10B cash vs $5.36B debt, net cash position |
| Cash Flow | Solid — FCF $314M (FY ended Dec 2025, 10-K), 12% margin |
| Efficiency | Strong — ROE 30%, ROA 2.9% |
Ownership (WEX)
| Insider Ownership | +1.32% |
|---|---|
| Institutional Ownership | +120.57% |
| Shares Outstanding | 34.08M |
| Float | 29.68M |
| Short % of Float | +10.70% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GMED | Globus Medical, Inc. | USD 81.66 | ▲ 3.79% |
| BAND | Bandwidth Inc. | USD 40.5 | ▼ 13.5% |
| EEFT | Euronet Worldwide, Inc. | USD 67.06 | ▲ 1.73% |
| PCTY | Paylocity Holding Corporation | USD 177.67 | ▲ 4.93% |
| PEGA | Pegasystems Inc. | USD 36.65 | ▲ 4.18% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt